Funding · Company
Arpeggio Biosciences, Inc.
Boulder, COSoftware & Technology
Arpeggio Biosciences, Inc. of Boulder, CO has disclosed $40M across 2 Form D offerings filed with the SEC between Sep 23, 2022 and Nov 24, 2025.
$40M
Total disclosed
2
Form D offerings
2017
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$20M
Form D · Nov 24, 2025 ↗
Q4 2025
· target $35M
$20M
Form D · Sep 23, 2022 ↗
Q3 2022
· target $20M
Filing details
HeadquartersBoulder, COIndustrySoftware & Technology (Other Technology)Incorporated2017SEC CIK0001786698Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →